Global Contract Pharmaceutical Manufacturing Market Growth, Share, Size, Trends and Forecast (2022 - 2028)
Segmented by Service Type;
Contract Manufacturing Organization (CMO) - Final dosage form manufacturing and Packaging, Contract Research Organization (CRO) - Drug Discovery, Preclinical Studies, Early Phase I - IIa, Phase IIa - III, Phase IIIb - IV, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management and Protocol Development.Segmented by Molecule Type;
Small Molecules and Large Molecules.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).Introduction
Global Contract Pharmaceutical Manufacturing Market (USD Million), 2018 - 2028
# | Global |
---|---|
2018 | 98.6 |
2019 | 104.0 |
2020 | 107.0 |
2021 | 118.3 |
2022 | 122.0 |
2023 | 145.5 |
2024 | 148.2 |
2025 | 170.2 |
2026 | 171.1 |
2027 | 190.5 |
2028 | 202.0 |
In the year 2021, the Global Contract Pharmaceutical Manufacturing Market was valued at USD 82,602.50 million. The size of this market is expected to increase to USD 123,222.70 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 5.9%.
Global Contract Pharmaceutical Manufacturing Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Contract Pharmaceutical Manufacturing Market |
Study Period | 2018 - 2028 |
Base Year (for Contract Pharmaceutical Manufacturing Market Size Estimates) | 2021 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Contract Pharmaceutical Manufacturing Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Contract Pharmaceutical Manufacturing Market Analysis
In this report, the Global Contract Pharmaceutical Manufacturing Market has been segmented by Service Type, Molecule Type and Geography. $xxbn blood glucose monitoring devices market outlook, 2023 - driven by the phenomenal sales growth of new revolutionary cgms (abbott's freestyle libre, contract manufacturing in pharma, dexcom's g6 cgm).
Global Contract Pharmaceutical Manufacturing Market, Segmentation by Service Type
The Global Contract Pharmaceutical Manufacturing Market has been segmented by Service Type into Contract Manufacturing Organization (CMO) and Contract Research Organization (CRO). The complete Global Contract Pharmaceutical Manufacturing Market segmentation by Service Type can be seen below:
- Global Contract Pharmaceutical Manufacturing Market, By Service Type
- Contract Manufacturing Organization (CMO)
- Final dosage form manufacturing
- Packaging
- Contract Research Organization (CRO)
- Drug Discovery
- Preclinical Studies
- Early Phase I - IIa
- Phase IIa - III
- Phase IIIb - IV
- Medical Coding and Writing
- Monitoring
- Clinical Data Management
- Bio-statistics
- Site Management
- Protocol Development
- Contract Manufacturing Organization (CMO)
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Service Types mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Service Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Contract Pharmaceutical Manufacturing Market, by Service Type (USD Million), 2018 - 2028
# | Contract Manufacturing Organization (CMO) | Contract Research Organization (CRO) |
---|---|---|
2018 | 88.1 | 96.1 |
2019 | 103.1 | 107.4 |
2020 | 112.0 | 112.8 |
2021 | 128.3 | 127.8 |
2022 | 135.1 | 148.1 |
2023 | 157.8 | 167.6 |
2024 | 172.2 | 192.9 |
2025 | 200.3 | 228.8 |
2026 | 208.7 | 273.0 |
2027 | 236.6 | 279.1 |
2028 | 261.5 | 299.6 |
Global Contract Pharmaceutical Manufacturing Market, Segmentation by Molecule Type
The Global Contract Pharmaceutical Manufacturing Market has been segmented by Molecule Type into Small Molecules and Large Molecules. The complete Global Contract Pharmaceutical Manufacturing Market segmentation by Molecule Type can be seen below:
- Global Contract Pharmaceutical Manufacturing Market, By Molecule Type
- Small Molecules
- Large Molecules
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Molecule Types mentioned above for historic (2018 - 2021) and forecast (2022 - 2028) periods with 2021 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Molecule Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Contract Pharmaceutical Manufacturing Market, by Molecule Type (USD Million), 2018 - 2028
# | Small Molecules | Large Molecules |
---|---|---|
2018 | 76.7 | 89.6 |
2019 | 85.0 | 105.5 |
2020 | 94.0 | 120.1 |
2021 | 101.0 | 140.6 |
2022 | 115.5 | 141.3 |
2023 | 129.3 | 159.9 |
2024 | 142.2 | 186.3 |
2025 | 151.9 | 203.2 |
2026 | 161.2 | 218.6 |
2027 | 169.3 | 249.0 |
2028 | 171.3 | 294.2 |
Global Contract Pharmaceutical Manufacturing Market, Segmentation by Geography
In this report, the Global Contract Pharmaceutical Manufacturing Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Contract Pharmaceutical Manufacturing Market Share (%), by Geographical Region, 2021
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Contract Pharmaceutical Manufacturing Market in all the Regions and Countries (specified above) for historic (2018 - 2021) and forecast (2022 - 2028) Periods with 2021 considered as the base year.
This report also provides an analysis of why the market size of Contract Pharmaceutical Manufacturing in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Contract Pharmaceutical Manufacturing Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Contract Pharmaceutical Manufacturing Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Contract Pharmaceutical Manufacturing Market will be discussed in detail in the full report.
- The new opportunities in Global Contract Pharmaceutical Manufacturing Market will be discussed in detail in the full report.
- Global Contract Pharmaceutical Manufacturing Market Drivers will be discussed in detail in the full report.
- Global Contract Pharmaceutical Manufacturing Market Restraints will be discussed in detail in the full report.
- Global Contract Pharmaceutical Manufacturing Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Contract Pharmaceutical Manufacturing Market. The opportunity map (by market segments; Service Type and Molecule Type) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Contract Pharmaceutical Manufacturing Market, Opportunity Map, By Region (2018 - 2028)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Contract Pharmaceutical Manufacturing Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Contract Pharmaceutical Manufacturing Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Contract Pharmaceutical Manufacturing Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. An industry analysis of the recent collaborations focused on the contract manufacturing of biologics, based on various parameters, such as the year the agreement was signed, type of agreement, focus area, types of biologics manufactured, therapeutic area and geographical regions. Top 10 ranking of contract manufacturing organizations in drug discovery as voted by the pharma iq network.. Contract manufacturing organisations (cmos) hand pharmaceutical and biologic manufacturers the freedom to prioritise their own internal capacities and enhance process efficiencies. The need to consolidate the cdmo industry pharma companies leveraging integrated offerings by contract development and manufacturing organisations (cdmos) continue to struggle to fully rationalise.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Contract Pharmaceutical Manufacturing Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Contract Pharmaceutical Manufacturing Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Contract Pharmaceutical Manufacturing Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Contract Pharmaceutical Manufacturing Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Contract Pharmaceutical Manufacturing Market include, Accenture plc, Cognizant Technology Solutions, ATOS SE, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH, Genpact Limited and Lonza Group.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Molecule Type
- Market Snapshot, By Region
- Market Opportunity Map
- Global Contract Pharmaceutical Manufacturing Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Contract Pharmaceutical Manufacturing Market, By Service Type, 2020-2030 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Contract Manufacturing Organization (CMO)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Final dosage form manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Packaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Final dosage form manufacturing
- Contract Research Organization (CRO)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Preclinical Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Early Phase I - IIa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Phase IIa - III
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Phase IIIb - IV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Medical Coding and Writing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Clinical Data Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Bio-statistics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Site Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Protocol Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Drug Discovery
- Contract Manufacturing Organization (CMO)
- Global Contract Pharmaceutical Manufacturing Market, By Molecule Type, 2020-2030 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Segment Trends
- Small Molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Large Molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
- Small Molecules
- Global Contract Pharmaceutical Manufacturing Market, By Geography, 2020-2030 (USD Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2019 - 2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2018 - 2028 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2018 - 2028 (USD Million)
- GCC
- North America
- Global Contract Pharmaceutical Manufacturing Market, By Service Type, 2020-2030 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Accenture plc
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Cognizant Technology Solutions
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- ATOS SE
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Catalent, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Covance, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Boehringer Ingelheim GmbH
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Genpact Limited
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Lonza Group
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Accenture plc
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2021, the Global Contrast-Enhanced Ultrasound Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global COPD and Asthma Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Cordyceps Sinensis and Militaris Extract Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2021, the Global Corticosteroids Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%